Pro Medicus (ASX:PME) Asset Impairment Charge : A$0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Pro Medicus Asset Impairment Charge?

Pro Medicus's Asset Impairment Charge for the six months ended in Dec. 2023 was A$0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.0 Mil.

Pro Medicus Asset Impairment Charge Historical Data

The historical data trend for Pro Medicus's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus Asset Impairment Charge Chart

Pro Medicus Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Asset Impairment Charge

Get a 7-Day Free Trial

Pro Medicus Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Pro Medicus Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

Pro Medicus Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Pro Medicus's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Pro Medicus (ASX:PME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (ASX:PME) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

PMCUF:USA PMC:Germany

Address

450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121

Website

https://www.promed.com.au

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.